“Patient Acceptability and Tolerability of Fentanyl Pectin Nasal Spray (FPNS) in the Treatment of Breakthrough Cancer Pain (BTCP): Results from a Double-Blind, Double-Dummy, Multiple-Crossover Study of FPNS versus Immediate-Release Morphine Sulphate (IRMS)”.